Table 2.

Assessment table of participants in LINC-II study (n = 240)

Administered assessment	Study time point
	Baseline	6-month	12-month
Demographics [24–26]	X		X
HIV testing and HCV diagnosis [27]	X		X
ART use and adherence [28]	X	X	X
Health care utilization [29]	X	X	X
Costs of illness and treatment in last month	X	X	X
Attitudes toward care coordination and care continuity [30]	X	X	X
Barriers to medical care [31]	X	X	X
Perceived discrimination in health care	X	X	X
DSM-5 opioid use disorder	X
Drug use [32, 33]	X	X	X
TLFB: opioids [34, 35]	X	X	X
Tobacco use [36, 37]	X
Alcohol use: AUDIT [38]	X		X
Opportunistic infections [39]		X	X
Medications	X	X	X
Pain assessment [40, 41]		X	X
HIV sex risk behaviors and reproductive health [42, 43]			X
Sexual partnersa	X		X
HIV risk categoriesa [44, 45]	X
HIV disclosurea [46, 47]	X
HIV stigmaa [48]	X		X
Substance use stigmaa	X		X
Barriers to medical care part 2a [31]	X	X	X
Depressive symptoms (CES-D)a [49, 50]	X		X
Anxiety (GAD-7)a [51]	X		X
Case manager questionsa		X	X
Partner violence and sexual assaulta [52]		X
Overdose and suicidea		X	X
Social support scale [53]	X
VR-12 health survey—MOS-HIV [54, 55]	X		X
Primary activity	X	X	X
Visit costs		X	X

^aSelf-administered